ORGANIZATION
Keidanren Calls for English Drug Filings to Be Opened to Japan-Based Firms
The Japan Business Federation, or Keidanren, is calling for Japanese drug makers and other companies with a presence in Japan to be allowed to submit common technical document (CTD) materials in English when filing new drugs for approval. The proposal…
To read the full story
Related Article
- MHLW Pharma Chief Eyes Wider Use of English Drug Filings to Stem Drug Loss
September 25, 2026
ORGANIZATION
- 60% of EFPIA Firms Could Cut Japan Trial Investments without Policy Reform
October 2, 2026
- JPMA to Complete Shift to Legal Entity on October 1
September 30, 2026
- Generic Use Rate Hits Record 90.4% in April-June: JGA
September 30, 2026
- JaDHA Calls for Digital Health Seat in Chuikyo Reform
September 28, 2026
- Digital Health Group Eager to Gain Full Seat at Chuikyo Table
September 25, 2026
The Wednesday TableShe had been on virtual calls since eight in the morning. The screen glowed. Her eyes burned. Plugged into Teams across time zones, she was digitally connected yet entirely isolated from the reality of Japan’s pharma market.She needed…





